The latest quarterly R&D expense is $23.37 Million with a QoQ Growth of +33.87%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $23.37M.
$23.37M
$23.37 Million
Q2 FY2026 · 2026-06-30
+33.87%
vs. $17.46M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $23.37M | +33.87% | +43.02% |
| Q1 FY2026Period end 2026-03-31 | $17.46M | -10.54% | +6.08% |
| Q4 FY2025Period end 2025-12-31 | $19.51M | +16.09% | +46.55% |
| Q3 FY2025Period end 2025-09-30 | $16.81M | +2.88% | +20.54% |
| Q2 FY2025Period end 2025-06-30 | $16.34M | -0.70% | +29.33% |
| Q1 FY2025Period end 2025-03-31 | $16.46M | +23.58% | +42.40% |
| Q4 FY2024Period end 2024-12-31 | $13.32M | -4.52% | +38.19% |
| Q3 FY2024Period end 2024-09-30 | $13.95M | +10.38% | +81.06% |
| Q2 FY2024Period end 2024-06-30 | $12.63M | +9.33% | +23.91% |
| Q1 FY2024Period end 2024-03-31 | $11.56M | +19.93% | +65.89% |
| Q4 FY2023Period end 2023-12-31 | $9.64M | +25.10% | N/A |
| Q3 FY2023Period end 2023-09-30 | $7.70M | -24.46% | N/A |
| Q2 FY2023Period end 2023-06-30 | $10.20M | +46.37% | N/A |
| Q1 FY2023Period end 2023-03-31 | $6.97M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
